cancer treatment
Emerging Technologies
Sergio Calvo, general manager of theranostics at GE HealthCare, discusses the organization's use of theranostics in cancer care and how the technology combines targeted therapy with diagnostic imaging for personalized oncology care.
The ISS National Lab and MicroQuin joined forces to analyze and pinpoint changes in cancer cells.
The cancer-care company will expand its reach within the healthcare system to provide more oncology patients access to its remote coordinated-care services.
Elekta’s radiation therapy offerings will now utilize GE HealthCare’s recently acquired MIM software.
Also, Lunit has received Taiwan's approval for its AI mammography solution.
Rutherford Health Chief Medical Officer Karol Sikora highlights the most pressing needs in cancer treatment today and how he envisages treatment decision-making in the next decade.
The company will expand its oncolytic viral therapy platform to combat cancer.
The service was unable to generate adequate revenue with its D2C model, which asked patients for a $3,000 enrollment payment alongside $20 in monthly fees.